Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.
Cunningham
Richard
R
Department of Microbiology, Derriford Hospital, Plymouth, PL6 8DH, UK.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile; D017714:Community-Acquired Infections; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D004761:Enterocolitis, Pseudomembranous / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D016017:Odds Ratio; D054328:Proton Pump Inhibitors; D012307:Risk Factors; D006113:United Kingdom / Q000453:epidemiology; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D014640:Vancomycin